Testosterone-encapsulated surfactant-free nanoparticles of poly(DL-lactide-co-glycolide):: Preparation and release behavior

被引:0
作者
Jeong, YI
Shim, YH
Song, KC
Park, YG
Ryu, HW
Nah, JW
机构
[1] Univ Paris 11, CNRS, UMR 8612, F-92296 Chatenay Malabry, France
[2] Univ Paris 06, F-75252 Paris 05, France
[3] Chonnam Natl Univ, Fac Appl Chem Engn, Kwangju 500757, South Korea
[4] Sunchon Natl Univ, Dept Polymer Sci & Engn, Choongnam 540742, South Korea
关键词
surfactant-free; poly(DL-lactide-co-glycolide); nanoparticles; dialysis; solvent diffusion;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Since surfactant or emulsifiers remained on the nanoparticle surface significantly affect the physicochemical properties, the biodegradation rate, the biodistribution, and the biocompatibility of nanoparticles, surfactant-free nanoparticles should be good candidate. surfactant-free PLGA nanoparticles were successfully prepared by both the dialysis method and the solvent diffusion method. The PLGA nanoparticles prepared using the solvent diffusion method has a smaller particle size than the dialysis method. The solvent diffusion method was better for a higher loading efficiency than the dialysis method but the nanoparticle yield was lower. Testosterone (TST) release from the PLGA nanoparticles was dependent on the particle size rather than the drug contents. Testosterone release from the PLGA nanoparticles prepared by the solvent diffusion method using acetone was faster than those prepared by the dialysis method. TST release from the PLGA nanoparticles prepared by the solvent diffusion method using acetone and the dialysis method using dimethylformamide (DMF) was completed for 4 days while the PLGA nanoparticles prepared by the dialysis method using acetone showed approximately 80% TST release after 4 days. Since the PLGA nanoparticle degradation ratio was below 20% within 5 days at all samples while TST release completed within 4 days, TST release was dependent on the diffusion mechanism rather than degradation.
引用
收藏
页码:1579 / 1584
页数:6
相关论文
共 24 条
  • [1] ALLEMANN E, 1993, EUR J PHARM BIOPHARM, V39, P173
  • [2] [Anonymous], INT J PHARM
  • [3] PREPARATION AND DEGRADATION OF SURFACTANT-FREE PLAGA MICROSPHERES
    CARRIO, A
    SCHWACH, G
    COUDANE, J
    VERT, M
    [J]. JOURNAL OF CONTROLLED RELEASE, 1995, 37 (1-2) : 113 - 121
  • [4] LIPOSOMES AND NANOPARTICLES IN THE TREATMENT OF INTRACELLULAR BACTERIAL-INFECTIONS
    COUVREUR, P
    FATTAL, E
    ANDREMONT, A
    [J]. PHARMACEUTICAL RESEARCH, 1991, 8 (09) : 1079 - 1086
  • [5] POLYSTYRENE-POLY(ETHYLENE GLYCOL) (PS-PEG2000) PARTICLES AS MODEL SYSTEMS FOR SITE-SPECIFIC DRUG-DELIVERY .2. THE EFFECT OF PEG SURFACE-DENSITY ON THE IN-VITRO CELL-INTERACTION AND IN-VIVO BIODISTRIBUTION
    DUNN, SE
    BRINDLEY, A
    DAVIS, SS
    DAVIES, MC
    ILLUM, L
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (07) : 1016 - 1022
  • [6] NANOCAPSULE FORMATION BY INTERFACIAL POLYMER DEPOSITION FOLLOWING SOLVENT DISPLACEMENT
    FESSI, H
    PUISIEUX, F
    DEVISSAGUET, JP
    AMMOURY, N
    BENITA, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 55 (01) : R1 - R4
  • [7] PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug
    Govender, T
    Stolnik, S
    Garnett, MC
    Illum, L
    Davis, SS
    [J]. JOURNAL OF CONTROLLED RELEASE, 1999, 57 (02) : 171 - 185
  • [8] BIODEGRADABLE LONG-CIRCULATING POLYMERIC NANOSPHERES
    GREF, R
    MINAMITAKE, Y
    PERACCHIA, MT
    TRUBETSKOY, V
    TORCHILIN, V
    LANGER, R
    [J]. SCIENCE, 1994, 263 (5153) : 1600 - 1603
  • [9] POLY(DL-LACTIDE) NANOCAPSULES CONTAINING DICLOFENAC .1. FORMULATION AND STABILITY STUDY
    GUTERRES, SS
    FESSI, H
    BARRATT, G
    DEVISSAGUET, JP
    PUISIEUX, F
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 113 (01) : 57 - 63
  • [10] ILLUM L, 1982, INT J PHARM, V12, P135